Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
15.82
+1.15 (7.84%)
Mar 31, 2026, 12:39 PM EDT - Market open
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $1.64 billion as of March 31, 2026. Its market cap has increased by 63.43% in one year.
Market Cap
1.64B
Enterprise Value
979.75M
1-Year Change
63.43%
Ranking
Category
Stock Price
$15.82
Market Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $1.64B, an increase of 132.34%. That is a compound annual growth rate of 16.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 1.53B | -20.63% |
| Dec 31, 2025 | 1.92B | 44.09% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recursion Pharmaceuticals | 1.55B |
| Soleno Therapeutics | 1.55B |
| Damora Therapeutics | 1.54B |
| Harmony Biosciences Holdings | 1.54B |
| Maze Therapeutics | 1.51B |
| Palvella Therapeutics | 1.51B |
| Vericel | 1.49B |
| Immunocore Holdings | 1.49B |